We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$26.1B
AUM Growth
+$3.27B
Cap. Flow
+$3.71B
Cap. Flow %
14.22%
Top 10 Hldgs %
13.68%
Holding
2,527
New
200
Increased
1,494
Reduced
642
Closed
151

Sector Composition

Rank Sector Weight
1 Healthcare 9.16%
2 Technology 8.66%
3 Financials 8.59%
4 Industrials 7.31%
5 Consumer Staples 6.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBL
1026
DoubleLine Opportunistic Credit Fund
DBL
$280M
$3.37M 0.01%
145,548
+83,819
+136% +$2.04M
IUSG icon
1027
iShares Core S&P US Growth ETF
IUSG
$33.7B
$3.37M 0.01%
82,838
+22,858
+38% +$942K
SPLK
1028
DELISTED
Splunk Inc
SPLK
$3.36M 0.01%
48,265
+1,276
+3% +$85.9K
PAY
1029
DELISTED
Verifone Systems Inc
PAY
$3.36M 0.01%
98,850
-1,807
-2% -$65.5K
HUM icon
1030
Humana
HUM
$46.2B
$3.35M 0.01%
17,525
+263
+2% +$48.8K
IM
1031
DELISTED
Ingram Micro
IM
$3.35M 0.01%
133,709
+14,121
+12% +$369K
PEG icon
1032
Public Service Enterprise Group
PEG
$37.7B
$3.34M 0.01%
85,137
-592
-0.7% -$24.6K
WES
1033
DELISTED
Western Gas Partners Lp
WES
$3.34M 0.01%
52,770
+13,171
+33% +$894K
ACM icon
1034
Aecom
ACM
$9.75B
$3.34M 0.01%
+100,982
New +$3.33M
EOI
1035
Eaton Vance Enhanced Equity Income Fund
EOI
$826M
$3.33M 0.01%
253,911
-1,440
-0.6% -$19.7K
THRM icon
1036
Gentherm
THRM
$1.27B
$3.33M 0.01%
60,652
+32,550
+116% +$1.73M
JKHY icon
1037
Jack Henry & Associates
JKHY
$11.1B
$3.32M 0.01%
51,331
+21,184
+70% +$1.41M
NUV icon
1038
Nuveen Municipal Value Fund
NUV
$1.91B
$3.32M 0.01%
344,834
+30,052
+10% +$293K
VDE icon
1039
Vanguard Energy ETF
VDE
$9.74B
$3.31M 0.01%
+30,974
New +$3.48M
DEM icon
1040
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$3.31M 0.01%
76,268
-16,175
-17% -$740K
PBA icon
1041
Pembina Pipeline
PBA
$27.6B
$3.31M 0.01%
102,437
+18,009
+21% +$603K
ICUI icon
1042
ICU Medical
ICUI
$4.61B
$3.31M 0.01%
34,580
+378
+1% +$35.3K
TPR icon
1043
Tapestry
TPR
$32.8B
$3.3M 0.01%
95,477
+12,179
+15% +$466K
HI
1044
DELISTED
Hillenbrand
HI
$3.29M 0.01%
107,049
+67,174
+168% +$2.07M
WST icon
1045
West Pharmaceutical
WST
$24.9B
$3.27M 0.01%
56,266
+5,169
+10% +$289K
FHI icon
1046
Federated Hermes
FHI
$4.72B
$3.25M 0.01%
97,173
+59,913
+161% +$2.07M
SSNC icon
1047
SS&C Technologies
SSNC
$18.6B
$3.25M 0.01%
104,100
+48,670
+88% +$1.49M
HOUS
1048
DELISTED
Anywhere Real Estate
HOUS
$3.25M 0.01%
69,556
+1,188
+2% +$55.2K
THQ
1049
abrdn Healthcare Opportunities Fund
THQ
$796M
$3.25M 0.01%
163,626
+5,682
+4% +$117K
SNV
1050
DELISTED
Synovus
SNV
$3.24M 0.01%
105,037
+3,223
+3% +$93.2K

Similar funds

Raymond James & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Raymond James & Associates held 2,527 positions worth $26.1B, up 14% from $22.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Raymond James & Associates deployed $3.71B of net new capital in Q2 2015, opening 200 new positions and adding to 1,494 existing holdings. Its largest new stake was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, down from 9.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Williams Companies, an estimated $47.1M trimmed.

  • Raymond James & Associates's largest Q2 2015 buy was AMEC Foster Wheeler plc: 809,014 shares worth $10.5M.
  • Raymond James & Associates added most to WisdomTree Europe Hedged Equity Fund in Q2 2015, an estimated $129M increase.
  • Raymond James & Associates's biggest Q2 2015 reduction was Williams Companies, cutting an estimated $47.1M.
  • Raymond James & Associates fully exited Allergan plc in Q2 2015, selling an estimated $76M.
  • Raymond James & Associates's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2015.
  • Raymond James & Associates opened 200 new positions and closed 151 in Q2 2015.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $26.1B.

Based on Raymond James & Associates's 13F filing for Q2 2015, filed 13 Aug 2015.